Novartis AG (SWX: NOVN)
Switzerland
· Delayed Price · Currency is CHF
91.06
-0.16 (-0.18%)
Nov 19, 2024, 5:30 PM CET
Novartis AG Employees
Novartis AG had 76,057 employees as of December 31, 2023. The number of employees decreased by 25,646 or -25.22% compared to the previous year.
Employees
76,057
Change (1Y)
-25,646
Growth (1Y)
-25.22%
Revenue / Employee
554.65K CHF
Profits / Employee
195.50K CHF
Market Cap
182.05B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 76,057 | -25,646 | -25.22% |
Dec 31, 2022 | 101,703 | -2,620 | -2.51% |
Dec 31, 2021 | 104,323 | -1,471 | -1.39% |
Dec 31, 2020 | 105,794 | 1,880 | 1.81% |
Dec 31, 2019 | 103,914 | -21,247 | -16.98% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Roche Holding AG | 103,605 |
Roche Holding AG | 103,605 |
Galderma Group AG | 6,545 |
Galenica AG | 7,902 |
SKAN Group AG | 1,527 |
Basilea Pharmaceutica AG | 147 |
DocMorris AG | 1,453 |
IVF Hartmann Holding AG | 273 |
Novartis AG News
- 10 hours ago - Novartis ranks first in 2024 Access to Medicine Index - GlobeNewsWire
- 1 day ago - Novartis, Ratio to collaborate on SSTR2 radiotherapeutic for cancer - Seeking Alpha
- 1 day ago - Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate - PRNewsWire
- 6 days ago - PPI, Novartis hold media workshop to enhance health literacy in managing cholesterol, promote heart health - BusinessMirror
- 7 days ago - Schrödinger gains on Novartis deal despite Q3 miss - Seeking Alpha
- 7 days ago - Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details - Benzinga
- 7 days ago - Cellares Appoints Ossama Eissa, Former Novartis, Lonza and Legend Biopharma Leader, as Chief Operating Officer - Business Wire
- 7 days ago - Schrödinger’s stock soars 9% as it enters collaboration pact with Novartis for up to about $2.5 billion in payments - MarketWatch